NCT04249557

Brief Summary

6,000 patients with HT and/or DM will be recruited to participate a 12-week EIM exercise intervention, which also involve consistent feedback and reminders using information technology (IT). The primary outcome will be improvement of blood pressure at 1-year. Other clinical outcomes will be obtained on recruitment (baseline), 12-week (immediately after EIM classes) and 1-year after recruitment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,000

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
Completed

Started Jul 2020

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 31, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

July 16, 2024

Status Verified

July 1, 2024

Enrollment Period

3.9 years

First QC Date

January 21, 2020

Last Update Submit

July 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • office blood pressure

    office systolic blood pressure

    Change from Baseline Systolic Blood Pressure at 3 months

Secondary Outcomes (5)

  • serum lipid level

    baseline, 3-month after recruitment (immediate after EIM class), 12-month after recruitment (end-of-study)

  • body fat percentage

    baseline, 3-month after recruitment (immediate after EIM class), 12-month after recruitment (end-of-study)

  • body mass index

    baseline, 3-month after recruitment (immediate after EIM class), 12-month after recruitment (end-of-study)

  • international physical activity questionnaire- short form

    baseline, 3-month after recruitment (immediate after EIM class), 12-month after recruitment (end-of-study)

  • office blood pressure

    baseline, 12-month after recruitment (end-of-study)

Study Arms (1)

EIM group

EXPERIMENTAL

This contains: A 12-week Exercise is medicine teaching class containing 6-18 patients per group (class size may be limited by social distancing policy in Hong Kong), homework are prescribed to participants to encourage regular exercise. The exercise level will be recorded by a tracker and provides feedback to the participants and physical trainer. The physical parameters such as fat percentage and blood pressure level will be feedback to the patients to encourage exercise. (If sports center are closed by the Government, the classes will be conducted online)

Behavioral: exercise is medicine

Interventions

a 12-week exercise classes program combined with other motivational skills, including feedback and information technology support. The whole program lasts for 1 year for each participant

EIM group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have a clinical diagnosis of primary HT and/or type II DM from clinical medical record
  • having less than 150 minutes of moderate intensity exercise per week OR having less than 75 minutes of intensive intensity exercise per week (this is set according to latest World Health Organization guideline)
  • who have used any mobile apps on their phone (because the intervention involve use of apps to monitor and remind regular exercise)

You may not qualify if:

  • patients with diagnosed chronic obstructive lung disease and recent stroke (within last 12 months)
  • Patients on 3 or more anti-hypertensive medications (on maximum or maximal tolerable doses) are excluded because these patients have resistant HT and may represent another spectrum of disease.
  • Patients with spinal cord compression, radiculopathy with active pain, or osteoarthritis of hips and knees that are on the waiting list for joint replacement surgery are excluded for safety reasons.
  • acute myocardial infarction in last 6 months
  • ongoing angina
  • uncontrolled cardiac arrhythmia
  • acute diseases including known active endocarditis/acute pulmonary embolism, pulmonary infarction, deep vein thrombosis, acute aortic dissection, acute myocarditis
  • known aortic stenosis
  • known heart failure
  • known obstructive left main coronary artery stenosis
  • uncontrolled ventricular rates
  • complete heart block
  • known hypertrophic obstructive cardiomyopathy
  • mental impairment that limit co-operation
  • resting blood pressure with systolic blood pressure \>180mmHg or diastolic blood pressure \>110mmHg
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lek Yuen Clinic

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

January 21, 2020

First Posted

January 31, 2020

Study Start

July 1, 2020

Primary Completion

May 30, 2024

Study Completion

June 30, 2024

Last Updated

July 16, 2024

Record last verified: 2024-07

Locations